Reckitt reported estimate-beating Q1 22 sales, with the 5.6% growth largely attributable to price increases in response to inflation. Health (+20.6%) and Nutrition (+20.4%) more than offset the larger than expected decline in Hygiene (-9%).
Not surprisingly, FY 22 top-line growth is now expected to be at the high end of the previous 1-4% range.
We will upgrade our estimates marginally to reflect the strong Q1 and upgraded outlook.
29 Apr 2022
Q1 22: Very healthy and nutritious start to 2022
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Q1 22: Very healthy and nutritious start to 2022
Reckitt Benckiser Group plc (RKT:LON) | 4,433 0 0.0% | Mkt Cap: 31,283m
- Published:
29 Apr 2022 -
Author:
Virendra Chauhan -
Pages:
3
Reckitt reported estimate-beating Q1 22 sales, with the 5.6% growth largely attributable to price increases in response to inflation. Health (+20.6%) and Nutrition (+20.4%) more than offset the larger than expected decline in Hygiene (-9%).
Not surprisingly, FY 22 top-line growth is now expected to be at the high end of the previous 1-4% range.
We will upgrade our estimates marginally to reflect the strong Q1 and upgraded outlook.